繁体中文

Lameditech of South Korea was listed on the KOSDAQ exchange on the 17th

947
2024-06-26 11:15:40
查看翻譯

On June 11, 2024, Korean laser medical equipment manufacturer Lameditech successfully completed its initial public offering and was listed on the KOSDAQ exchange on the 17th.

Last month, its public offering price was fixed at 16000 Korean won. In this public offering, Lameditech issued a total of 1298000 shares, raising approximately 20.8 billion Korean won. Since Lameditech's debut on KOSDAQ, as of 1pm on the 17th, its stock price has risen 98.1% to 31700 Korean won, with a market value of over 270 billion Korean won.

After investigation, Lameditech was founded in 2012 and is an enterprise that develops beauty and medical device products based on ultra small and high-power laser source technology. Lameditech's laser technology reduces the laser oscillator that determines the size of the laser by 90-95%, achieving high-power laser beam transmission while improving portability.

The company's main products include beauty equipment Puracell, excimer light K-Bum, and needle free laser blood collection equipment Handyray.
Among them, needle free laser blood collection equipment was the foundation of Lameditech's establishment. As early as 2018, the device obtained FDA certification in the United States. Up to now, Lameditech's first laser blood collection device has been launched in the United States, Japan, Europe and other overseas markets, which is crucial for the diagnosis and treatment of diabetes patients.

But in 2023, Lameditech's annual sales were only 2.9 billion Korean won, with an operating deficit of up to 3.5 billion Korean won. According to the securities documents corrected by Lameditech on the 28th, its sales in the first quarter of 2024 were approximately KRW 1 billion, and the confirmed sales in the second quarter as of now are approximately KRW 1.6 billion.

Regarding this, Lameditech expects its sales to reach 9.2 billion Korean won and operating profit to reach 1 billion Korean won in 2024. At the same time, as Lameditech is currently focusing on developing overseas markets, it has sufficient confidence in its performance growth after going public.
It is understood that Choi Jong seok is the current CEO of Lameditech and the largest shareholder and founder of the company. Choi holds a 5.26% stake in Lameditech.

In fact, Choi worked at B&B Systems, which was spun off from the SEMES and medical equipment departments of Samsung Electronics, and founded Lameditech after leaving.

It is worth mentioning that the third largest shareholder of Lameditech is Boditech, a company founded in 1998 that focuses on the production and sales of in vitro diagnostic equipment. In 2023, it achieved sales of KRW 134.2 billion and operating profit of KRW 28.5 billion.

As early as 2015, when Lamediatech was still in its infancy, Boditech invested 900 million Korean won and held 600000 shares. It did not make further investments for the next nine years and now holds 6.9% of Lamediatech's shares. There is a strong cooperative relationship between the two that goes beyond simple equity investment.

In May of this year, Boditech announced the signing of a global sales agreement with Lametech for the laser blood collection device Handyray, which will have a synergistic effect with Boditech's main in vitro analysis and diagnostic equipment.

Source: OFweek

相關推薦
  • Automated methods for background estimation in laser spectroscopy

    A new automated method for spectral background estimation in laser spectroscopy ensures the accuracy of quantitative analysis with minimal human intervention.When using laser-induced breakdown spectroscopy in spectral analysis, scientists may encounter various obstacles. The most common challenge faced by scientists when conducting elemental analysis is to optimize the interaction between the lase...

    2023-11-24
    查看翻譯
  • An efficient femtosecond pulse amplification technique for extracting the maximum stored energy in fiber laser amplifiers

    The well-known journal Optica published a paper in November 2024 titled "Near complete extraction of maximum stored energy from large core fibers using coherent pulse stacking amplification of femtosecond pulses"The authors of the paper were the University of Michigan, Lawrence Berkeley National Laboratory, Peking University, and the German Institute of Synchrotron Radiation.The specific technique...

    2024-11-13
    查看翻譯
  • Singapore MetaOptics seeks to raise funds for the development of superlenses

    MetaOptics, a 2021 startup based in Singapore with expertise in metalenses and related optical components, is aiming to raise net proceeds of S$4 million (approximately US$3.1 million) by listing on the local “Catalist” stock exchange.Targeting emerging applications in smart phones, contactless 3D biometrics modules, tiny pocket projectors, lidar sensors, and augmented and virtual reality (AR/VR) ...

    09-03
    查看翻譯
  • NLIGHT announces financial performance for the fourth quarter and full year of 2024

    Recently, nLIGHT, a manufacturer of high-power semiconductors and fiber lasers, announced its financial performance for the fourth quarter and full year of 2024.financial summaryTotal revenue: 198.5 million US dollars, a decrease from 209.9 million US dollars in 2023, due to a decline in sales in the laser product department.Operating loss: A loss of $65.6 million, compared to a loss of $46.8 mill...

    03-04
    查看翻譯
  • Ultra fast laser nova PulseX Laser completes over 10 million yuan of financing

    PulseX Laser, a rising star in the field of ultrafast lasers, has recently completed a financing of over 10 million yuan, with this round of financing exclusively invested by Changlei Capital.As a representative of the forefront of technology today, ultrafast lasers play an important role in many industries. In the field of material processing, ultrafast lasers, with their ultra short pulse width ...

    2024-07-09
    查看翻譯